These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7539571)

  • 1. [Treatment of acute urine retention caused by benign prostatic hypertrophy with an LH-RH agonist (Goserelin)].
    Puyol Pallas M; Gómez Parada J
    Actas Urol Esp; 1995 Feb; 19(2):118-22. PubMed ID: 7539571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holmium laser prostatic resection for patients presenting with acute urinary retention.
    Anderson CB; Helfand BT; McVary KT
    BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute urinary retention: medical management and the identification of risk factors for prevention.
    Khastgir J; Khan A; Speakman M
    Nat Clin Pract Urol; 2007 Aug; 4(8):422-31. PubMed ID: 17673913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial laser coagulation of the prostate for management of acute urinary retention.
    Nishizawa K; Kobayashi T; Watanabe J; Ogura K
    J Urol; 2003 Sep; 170(3):879-82. PubMed ID: 12913721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
    Trachtenberg J
    BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doksazozin "Cardura" in acute urinary retention caused by benign prostatic hyperplasia].
    Perepanova TS; Kamalov AA; Siniukhin VN; Gorokhnov AV; Khazan PL; Orlova EV
    Urologiia; 2001; (3):18-20. PubMed ID: 11505534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
    Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
    BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
    Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
    Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.
    Slawin KM; Kattan MW; Roehrborn CG; Wilson T
    Urology; 2006 Jan; 67(1):84-8. PubMed ID: 16413338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course in patients with BPH operated for acute urine retention].
    Featherston M; Chechile G; Sanchotene E; Segarra J; Caicedo P; Ortiz A; Ferro E; Vicente J; Villavicencio H
    Actas Urol Esp; 1994 Jan; 18(1):39-42. PubMed ID: 7514843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of at-risk patients: dynamic variables.
    Emberton M
    BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sublingual isosorbide dinitrate on acute urinary retention due to benign prostatic hyperplasia.
    Tadayyon F; Izadpanahi M; Aali S; Mazdak H; Khorrami MH
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):782-5. PubMed ID: 22805391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.